Archive for Nancy Fliesler
Two neuroscience rock stars elected to the National Academy of Medicine
Beth Stevens, PhD, and Elizabeth Engle, MD, are the latest Boston Children’s Hospital researchers to be elected to the prestigious National Academy of Medicine. Their election, together with Daphne Haas-Kogan, MD, brings Boston Children’s total number of current NAM members to 22. Both scientists hail from the F.M. Kirby Neurobiology Center at Boston Children’s and are ... Read More about Two neuroscience rock stars elected to the National Academy of Medicine
Most parents of children with advanced cancer don’t recognize their low chance of cure
End-of-life care for children with advanced cancer is often very intensive, and can cause much suffering. When parents recognize that a cure is unlikely, they often choose to spare their children from aggressive treatments and focus on the quality of their child’s remaining time. But a study published Oct. 4 in the journal Cancer finds ... Read More about Most parents of children with advanced cancer don’t recognize their low chance of cure
Racial differences in response to asthma therapies, and other AsthmaNet lessons
African Americans have higher rates of serious asthma attacks, hospitalizations, and asthma-related deaths than whites. Now, a large multicenter study of African Americans with poorly controlled asthma finds that one size doesn’t fit all when it comes to common asthma treatments. Results appear in The New England Journal of Medicine (NEJM). The randomized study had ... Read More about Racial differences in response to asthma therapies, and other AsthmaNet lessons
Against all odds: Mila’s unique mutation, and her own custom drug
Ed. note: Mila passed away in February 2021, at age 10. The Mila’s Miracle Foundation continues to work to pave a pathway for personalized treatments. The FDA recently released a draft guidance on testing custom drugs such as Mila’s in patients. As a baby and toddler, Mila was healthy, active, and — in some ways ... Read More about Against all odds: Mila’s unique mutation, and her own custom drug
Shooting for the moon: From diagnosis to custom drug, in one year
Ed. note: Mila passed away in February 2021, at age 10. The Mila’s Miracle Foundation continues to work to pave a pathway for personalized treatments. The FDA recently released a draft guidance on testing custom antisense oligonucleotides (ASOs) in patients. One weekend in January 2017, Timothy Yu, MD, PhD, was relaxing at home when his ... Read More about Shooting for the moon: From diagnosis to custom drug, in one year
Diet, the microbiome, and how insulin resistance causes metabolic syndrome
Up to a third of U.S. adults have metabolic syndrome, a constellation of high blood pressure, high blood sugar, excess body fat around the waist, and abnormal cholesterol levels. Now considered to be epidemic, metabolic syndrome increases people’s risk of diabetes, heart disease, and stroke, as well as kidney and neurodegenerative disease. Metabolic syndrome is ... Read More about Diet, the microbiome, and how insulin resistance causes metabolic syndrome
Online data mining adds to the picture of vaping-related lung disease
Severe lung disease related to vaping has been surging across the U.S., with the eighth death confirmed last week by the Centers for Disease Control and Prevention. A brief report in The New England Journal of Medicine suggests that online data-mining tools can supplement traditional public health surveillance and help officials stay ahead of this sudden epidemic. ... Read More about Online data mining adds to the picture of vaping-related lung disease
Targeting a rogue T cell prevents and reverses multiple sclerosis in mice
Multiple sclerosis is an autoimmune disease affecting both adults and children. It’s driven by “helper” T cells, white blood cells that mount an inflammatory attack on the brain and spinal cord, degrading the protective myelin sheath that covers nerve fibers. But there are many different kinds of T helper cells, and up until now, no ... Read More about Targeting a rogue T cell prevents and reverses multiple sclerosis in mice
An advance for drug-eluting contact lenses: Delivery to the back of the eye
Drug-eluting contact lenses, which gradually release drugs into the eye, offer a promising alternative to daily eye drops, which can be unpleasant and hard for patients to properly administer. In a 2016 pre-clinical study of glaucoma, the engineered lenses lowered eye pressure at least as well as daily eye drops. New work from Massachusetts Eye ... Read More about An advance for drug-eluting contact lenses: Delivery to the back of the eye
Babies’ EEG patterns predict whether they will develop autism
Signs of autism spectrum disorder (ASD) typically start to become apparent only in a child’s second year of life or later, but earlier identification could allow children to receive interventions as babies, when they have greater brain plasticity and thus may receive more benefit. A new study in Nature Communications finds that periodic EEGs in ... Read More about Babies’ EEG patterns predict whether they will develop autism